•y•y•y•y•yThe CAGE is more accurate <strong>in</strong> classify<strong>in</strong>g males than females (McHugo etal., 1993). The <strong>in</strong>strument underestimates alcohol problems among women(Bisson et al., 1999; Cherpitel, 2002; Matano et al., 2002; Moore, Beck,& Babor, 2002). The CAGE also has lower sensitivity among Caucasianwomen than African-American women. (Bradley, Boyd-Wickizer, Powell, &Burman, 1998)The CAGE is more sensitive among African Americans than Caucasians(Cherpitel 2002)The CAGE is not recommended for use with adolescents (Hays & Ellickson,2001; Knight et al., 2003), <strong>and</strong> has performed poorly <strong>in</strong> college samples(Bisson et al., 1999)The CAGE has low sensitivity among older psychiatric samples (O'<strong>Co</strong>nnellet al., 2004)With<strong>in</strong> general population samples, no cut<strong>of</strong>f score for <strong>the</strong> CAGE yieldedgood specificity, sensitivity, <strong>and</strong> positive predictive value at <strong>the</strong> same time(Bisson et al., 1999)Availability <strong>and</strong> <strong>Co</strong>stThe CAGE is a public doma<strong>in</strong> screen<strong>in</strong>g <strong>in</strong>strument, <strong>the</strong> word<strong>in</strong>g <strong>and</strong> scor<strong>in</strong>g forwhich can be found at http://pubs.niaaa.nih.gov/publications/arh21-4/348.pdf, or<strong>in</strong> <strong>the</strong> document: Detect<strong>in</strong>g alcoholism: The CAGE questionnaire. Journal <strong>of</strong> <strong>the</strong>American Medical Association, 252, 1905–1907.The Dartmouth <strong>Assessment</strong> <strong>of</strong> Lifestyle Instrument (DALI)The DALI is an 18-item, <strong>in</strong>terview-adm<strong>in</strong>istered scale that exam<strong>in</strong>es lifetimealcohol, cannabis, <strong>and</strong> coca<strong>in</strong>e use disorders among persons with severe mentalillness. The DALI is a composite <strong>of</strong> several different <strong>in</strong>struments, <strong>and</strong> <strong>in</strong>cludesthree items from <strong>the</strong> Life-Style Risk <strong>Assessment</strong> Interview, <strong>and</strong> <strong>the</strong> rema<strong>in</strong><strong>in</strong>g 15items from <strong>the</strong> Reasons for Drug Use <strong>Screen<strong>in</strong>g</strong> Test, <strong>the</strong> TWEAK, <strong>the</strong> CAGE, <strong>the</strong>Drug Abuse <strong>Screen<strong>in</strong>g</strong> Test (DAST), <strong>and</strong> <strong>the</strong> Addiction Severity Index (ASI). This<strong>in</strong>strument is <strong>in</strong> <strong>the</strong> developmental stage, <strong>and</strong> it has not been studied extensivelyamong broad sets <strong>of</strong> cl<strong>in</strong>ical populations.Positive Features•y The DALI has good specificity (.80) <strong>and</strong> sensitivity (1.00) <strong>in</strong> identify<strong>in</strong>gsubstance abuse among persons with mental disorders (Rosenberg et al.,1998)•y Inter-rater reliability ranges from .86–.98 (Rosenberg et al., 1998). Testretestreliability coefficient <strong>of</strong> .90 has been demonstrated (Rosenberg et al.,1998)•y The <strong>in</strong>strument requires approximately six m<strong>in</strong>utes to adm<strong>in</strong>ister, <strong>and</strong> iseasy to score75
<strong>Co</strong>ncerns•y•y•yThe DALI was developed <strong>and</strong> validated on newly admitted psychiatric<strong>in</strong>patients <strong>in</strong> a predom<strong>in</strong>antly Caucasian, rural populationFuture research is needed to validate its use <strong>in</strong> ethnically <strong>and</strong> culturallydiverse populations, <strong>and</strong> <strong>in</strong> crim<strong>in</strong>al justice <strong>and</strong> substance abuse treatmentsett<strong>in</strong>gsThe <strong>in</strong>strument only exam<strong>in</strong>es alcohol, cannabis, <strong>and</strong> coca<strong>in</strong>e use disordersAvailability <strong>and</strong> <strong>Co</strong>stThe DALI <strong>in</strong>strument, scor<strong>in</strong>g <strong>in</strong>structions, <strong>and</strong> cut<strong>of</strong>f scores can be obta<strong>in</strong>edfree <strong>of</strong> charge from <strong>the</strong> Dartmouth Psychiatric Research Center at http://dms.dartmouth.edu/prc/<strong>in</strong>struments/dali/ or at http://dms.dartmouth.edu/prc/.Drug Abuse <strong>Screen<strong>in</strong>g</strong> Test (DAST)The DAST (Sk<strong>in</strong>ner, 1982) is a brief screen<strong>in</strong>g <strong>in</strong>strument that exam<strong>in</strong>essymptoms <strong>of</strong> drug dependence. Several versions <strong>of</strong> <strong>the</strong> DAST are available,<strong>in</strong>clud<strong>in</strong>g <strong>the</strong> DAST-28, DAST-20, DAST-10, <strong>and</strong> DAST for Adolescents (DAST-A). The DAST reviews drug <strong>and</strong> alcohol problems occurr<strong>in</strong>g <strong>in</strong> <strong>the</strong> last 12 months.Items from <strong>the</strong> DAST were developed to align with those developed for <strong>the</strong>Michigan Alcoholism <strong>Screen<strong>in</strong>g</strong> Test (MAST). The DAST can be adm<strong>in</strong>isteredthrough paper <strong>and</strong> pencil or computerized versions (Mart<strong>in</strong>o, Grilo, & Fehon,2000).Positive Features•y The DAST is brief to adm<strong>in</strong>ister <strong>and</strong> is easily scored•y The DAST-10 has good convergent validity with <strong>the</strong> SCID <strong>in</strong> detect<strong>in</strong>galcohol problems, <strong>and</strong> shows <strong>in</strong>cremental validity over <strong>the</strong> SCID alone forthis purpose (Maistro et al., 2000a, 2000b)•y The DAST-10 <strong>and</strong> DAST-20 have been found to have high <strong>in</strong>ternalconsistency, <strong>and</strong> good test-retest reliability <strong>and</strong> positive predictive valuefor DSM diagnoses (Carey et al., 2003; <strong>Co</strong>cco & Carey, 1998; Maistro et al.,2000a, 2000b; Mart<strong>in</strong>o et al., 2000; McCann et al., 2000; Peters et al., 2000)•y The DAST can dist<strong>in</strong>guish between <strong>in</strong>dividuals with primary alcoholproblems, those with primary drug problems, <strong>and</strong> those with both sets <strong>of</strong>problems (<strong>Co</strong>cco & Carey, 1998)•y The DAST was found to be more effective than several o<strong>the</strong>r drug screen<strong>in</strong>g<strong>in</strong>struments <strong>in</strong> identify<strong>in</strong>g drug dependence disorders among <strong>of</strong>fenders(Peters et al., 2000)•y The DAST-A has been found to be a reliable <strong>and</strong> valid screen<strong>in</strong>g devicefor use with adolescents <strong>in</strong> psychiatric sett<strong>in</strong>gs (Mart<strong>in</strong>o et al., 2000). TheDAST-A is more likely to underestimate than overestimate substance useproblems76
- Page 1:
Screening and Assessmentof Co-Occur
- Page 5 and 6:
Screening Instruments for Co-Occurr
- Page 12 and 13:
daunting task, and often requires t
- Page 14 and 15:
Importance of Screening and Assessm
- Page 16 and 17:
•y•y•y•y•y•y•y•y•
- Page 18 and 19:
Developing a Comprehensive Screenin
- Page 20 and 21:
•y•y•y•y•y•y•y•y•
- Page 22 and 23:
These areas of cognitive and behavi
- Page 24 and 25:
•y•y•y•y•y•y•y•yAlc
- Page 26 and 27:
frequency of drug testing may be ta
- Page 28 and 29:
offer expanded tests that also incl
- Page 30 and 31:
self-disclosure of mental health or
- Page 32 and 33:
should be determined by the severit
- Page 34 and 35: Special Clinical Issues in Screenin
- Page 36: suicide screening is important for
- Page 39 and 40: Maintaininga staff ofdiverse ethnic
- Page 41 and 42: The MHSF-III and the GAIN-SS were f
- Page 43 and 44: Key Information to Include in Asses
- Page 45 and 46: •y•y`` Vocational and education
- Page 47 and 48: approximately two hours. Either the
- Page 49 and 50: Texas Christian University Drug Scr
- Page 51 and 52: & Cirimele, 2006). Hair testing can
- Page 53 and 54: Appendix B: Screening Instruments f
- Page 55 and 56: Suicide Probability Scale (SPS)The
- Page 57 and 58: Positive Features•y•y•yThe TS
- Page 59 and 60: Appendix D: Screening Instruments f
- Page 61 and 62: Positive Features•y•y•y•yTh
- Page 63 and 64: Positive Features•y•y•y•y
- Page 65 and 66: Appendix F: Screening Instruments T
- Page 67 and 68: Availability and CostThe CAMH-CDS i
- Page 69 and 70: and one Axis II disorder (antisocia
- Page 71 and 72: Appendix G: Screening Instruments f
- Page 73 and 74: prior hospitalization for mental he
- Page 75 and 76: •yThe instrument has been used wi
- Page 77 and 78: •yThe instrument has not been use
- Page 79 and 80: Appendix H: Screening Instruments f
- Page 81 and 82: Positive Features•y•y•y•y
- Page 83: have you felt you ought to Cut down
- Page 87 and 88: •y•y•y•y•y•y•ywith sc
- Page 89 and 90: Concerns80•y•y•y•y•y•y
- Page 91 and 92: Concerns•y The validity of the SS
- Page 93 and 94: Appendix I: Recommended Instruments
- Page 95 and 96: Concerns•y•y•y•yReliabiliti
- Page 97 and 98: •y•y•y•yScales and profile
- Page 99 and 100: •y•yand non-interpretable resul
- Page 101 and 102: Appendix L: Assessment Instruments
- Page 103 and 104: Philadelphia, PA 19106, (215) 399-0
- Page 105 and 106: treatment setting. Treatment progra
- Page 107 and 108: Concerns•y•y•yThe CIDI is qui
- Page 109 and 110: •y•y•yThe PDSQ has been used
- Page 111 and 112: Both a Research Version and a Clini
- Page 113 and 114: 104
- Page 115 and 116: Bastiaens, L., Riccardi, K., & Sakh
- Page 117 and 118: Carey, K. B., Carey, M. P., & Chand
- Page 119 and 120: Demmel, R., Beck, B., Richter, D.,
- Page 121 and 122: Gray, B. T. (2001). A factor analyt
- Page 123 and 124: Kessler, R. C., Wittchen, H. U., Ab
- Page 125 and 126: McLellan, A. T., Cacciola, J. S., &
- Page 127 and 128: Nochajski, T. H., & Stasiewicz, P.
- Page 129 and 130: Rollnick, H., Heather, N., Gold, R.
- Page 131 and 132: Teitelbaum L. M., & Mullen, B. (200
- Page 133: Zimmerman, M., & Sheeran, T. (2003)